Fabio M Iwamoto

8PUBLICATIONS
123CO-AUTHORS
Immunogenetics (incl. genetic immunology)Radiation therapyGene and molecular therapyMolecular targetsPredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Nov 08, 2024
Re-Irradiation Plus Pembrolizumab: A Phase II Study for Patients with Recurrent Glioblastoma.

Fabio M Iwamoto, Shyam K Tanguturi, Lakshmi Nayak

|Aug 23, 2023
MGMT Promoter Methylation Predicts Overall Survival after Chemotherapy for 1p/19q-Codeleted Gliomas.

Connor J Kinslow, Ali I Rae, Kekoa Taparra

|Feb 05, 2022
ERK1/2 phosphorylation predicts survival following anti-PD-1 immunotherapy in recurrent glioblastoma.

Víctor A Arrieta, Andrew X Chen, J Robert Kane

Pageof 2